Diethylstilbestrol-induced estrogen receptor-dependent [Ca 2+]i rises and apoptosis in Chinese hamster ovary (CHO) cells

Journal of Receptors and Signal Transduction

Volumn 28, Issue 3, 2008, Pages 307-322

  Roan, Cherng Jau ^a   Huang, Chorng Chih ^b   Cheng, He Hsiung ^c   Chien, Jau Min ^a   Chou, Chiang Ting ^d   Lin, Ko Long ^d   Liu, Shiuh Inn ^d   Lu, Yih Chau ^d   Chang, Hong Tai ^d   Huang, Jong Khing ^d   Jan, Chung Ren ^d  

^a PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^b TZU HUI INSTITUTE OF TECHNOLOGY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Ca2+; CHO K1 cells; DES; Fura 2; WST 1

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; CALCIUM; DIETHYLSTILBESTROL; ESTROGEN RECEPTOR; PHOSPHOLIPASE C;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL VIABILITY; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; NONHUMAN;

ANIMALS; APOPTOSIS; CALCIUM; CALCIUM SIGNALING; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; DIETHYLSTILBESTROL; ESTRADIOL; ESTRENES; FURA-2; INTRACELLULAR SPACE; PYRROLIDINONES; RECEPTORS, ESTROGEN; TYPE C PHOSPHOLIPASES;

CRICETULUS GRISEUS;

EID: 45849151703     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1080/10799890802092237     Document Type: Article

References (36)

1. Newbold RR, Padilla-Banks E, Jefferson WN. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 2006, 147, S11-S17.
2. Rubin MM. Antenatal exposure to DES: Lessons learned...future concerns. Obstet Gynecol Surv 2007, 62, 548-555.
3. Tayama S, Nakagawa Y, Tayama K. Genotoxic effects of environmental estrogen-like compounds in CHO-K1 cells. Mutat Res 2007, Aug 19; [Epub ahead of print]
4. 2+/calmodulin-dependent protein kinase II activity and its relation to performance in passive avoidance response and long-term potentiation formation in mice prenatally exposed to diethylstilbestrol. Neuroscience 2007, 144, 1415-1424.
5. Li X, Zhang S, Safe S. Activation of kinase pathways in MCF-7 cells by 17beta-estradiol and structurally diverse estrogenic compounds. J Steroid Biochem Mol Biol 2006, 98, 122-132.
6. 2+ uptake by estrogen receptor agonists and antagonists. Br J Pharmacol 2005, 145, 862-871.
7. Samadi A, Cenedella RJ, Carlson CG. Diethylstilbestrol increases intracellular calcium in lens epithelial cells. Pflugers Arch 2005, 450, 145-154.
8. 2+ in PC3 human prostate cancer cells. Prostate 2001, 47, 141-148.
9. 2+ handling and cell viability in human breast cancer cells. Chin J Physiol 2003, 46, 187-192.
10. Chen YC, Chen SJ, Chang HT, Huang JK, Wang JL, Tseng LL, Chang HJ, Su W, Law YP, Chen WC, Jan CR. Mechanisms of diethylstilbestrol-induced calcium movement in MG63 human osteosarcoma cells. Toxicol Lett 2001, 122, 245-253.
11. 2+ influx. Mol Pharmacol 2004, 66, 702-707.
12. Dobrydneva Y, Williams RL, Katzenellenbogen JA, Ratz PH, Blackmore PF. Diethylstilbestrol and tetrahydrochrysenes are calcium channel blockers in human platelets: relationship to the stilbene pharmacophore. Thromb Res 2003, 110, 23-31.
13. Derfoul A, Lin FJ, Awumey EM, Kolodzeski T, Hall DJ, Tuan RS. Estrogenic endocrine disruptive components interfere with calcium handling and differentiation of human trophoblast cells. J Cell Biochem 2003, 89, 755-770.
14. 2+ channels. Biochem Biophys Res Commun 2003, 310, 261-266.
15. Oda T, Tanaka M, Sasaki T. Cytotoxicity of synthetic estrogen and related compounds in various tumor-derived cells. Biol Pharm Bull 2001, 24, 1142-1144.
16. Konac E, Ekmekci A, Barkar V, Yilmaz A, Erbas D. Effects of diethylstilbestrol in human lymphocytes in vitro: a dose and time-dependent study on genotoxic, cytotoxic and apoptotic effects. Mol Cell Biochem 2005, 276, 45-53.
17. Robertson CN, Roberson KM, Padilla GM, O'Brien ET, Cook JM, Kim CS, Fine RL. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst 1996, 88, 908-917.
18. 2+ channels activated by endothelin-1 in CHO cells expressing endothelin-A or endothelin-B receptors. Am J Physiol Cell Physiol 2001, 281, C1676-C1685.
19. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993, 361, 315-325.
20. Berridge MJ. Elementary and global aspects of calcium signalling. J Physiol 1997, 499, 291-306.
21. Bootman MD, Berridge MJ, Roderick HL. Calcium signalling: More messengers, more channels, more complexity. Curr Biol 2002, 12, R563-R565.
22. Annunziato L, Amoroso S, Pannaccione A, Cataldi M, Pignataro G, D'Alessio A, Sirabella R, Secondo A, Sibaud L, Di Renzo GF. Apoptosis induced in neuronal cells by oxidative stress: Role played by caspases and intracellular calcium ions. Toxicol Lett 2003, 139, 125-133.
23. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260, 3440-3450.
24. i rises and death in human hepatoma cells. Naunyn Schmiedebergs Arch Pharmacol 2007, 376, 185-194.
25. i elevation. Toxicol Sci 2007, 100, 109-117.
26. 2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells. Toxicology 2007, 231, 21-29.
27. 2+-ATPase. Proc Natl Acad Sci USA 1990, 87, 2466-2470.
28. Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, Fisher SK. The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation. J Biol Chem 1991, 266, 23856-23862.
29. Florenzano F, Viscomi MT, Cavaliere F, Volonte C, Molinari M. The role of ionotropic purinergic receptors (P2X) in mediating plasticity responses in the central nervous system. Adv Exp Med Biol 2006, 557, 77-100.
30. Tsien RY. New calcium indicators and buffers with high selectivity against magnesium and protons: Design, synthesis, and properties of prototype structures. Biochemistry 1980, 19, 2396-3404.
31. Huynh HT, Pollak M. Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res 1993, 53, 5585-5588.
32. Shukuwa K, Izumi S, Hishikawa Y, Ejima K, Inoue S, Muramatsu M, Ouchi Y, Kitaoka T, Koji T. Diethylstilbestrol increases the density of prolactin cells in male mouse pituitary by inducing proliferation of prolactin cells and transdifferentiation of gonadotropic cells. Histochem Cell Biol 2006, 126, 111-123.
33. Du Mond JW Jr, Singh KP, Roy D. The biphasic stimulation of proliferation of Leydig cells by estrogen exposure. Int J Oncol 2001, 18, 623-628.
34. Geisler J, Haynes B, Anker G, Helle H, Ekse D, Dowsett M, Lønning PE. Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients. J Steroid Biochem Mol Biol 2005, 96, 415-422.
35. Kemp HA, Read GF, Riad-Fahmy D, Pike AW, Gaskell SJ, Queen K, Harper ME, Griffiths K. Measurement of diethylstilbestrol in plasma from patients with cancer of the prostate. Cancer Res 1981, 41, 4693-4697.
36. Watson CS, Bulayeva NN, Wozniak AL, Alyea RA. Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids 2007, 72, 124-134.